Lytix Biopharma's Other Investors

Lytix Biopharma raised a round of funding on , .

Pre clinical developer of lytic peptide drugs for the treatment of resistant bacterial, fungal infections and tumor progression, closed a $10.4M Series D financing. oncology…

Articles about Lytix Biopharma's Other Investors: